ISCAF: Intrastromal Correction of Ametropia by a Femtosecond Laser

Sponsor
20/10 Perfect Vision (Industry)
Overall Status
Unknown status
CT.gov ID
NCT00928122
Collaborator
(none)
200
3
5
53
66.7
1.3

Study Details

Study Description

Brief Summary

This study evaluates the intrastromal correction of ametropia with a femtosecond laser made by 20/10 PERFECT VISION. This laser generates a beam of ultrashort, infrared pulses which enables very precise cuts in the cornea. By these cuts lamellae of the cornea are separated locally, and in the consequence the curvature of the cornea is changed, and the correction of the diagnosed ametropia can be achieved. On the contrary to cuts which are generated with a sharp knife, the cuts generated when using a laser can be generated just inside the cornea without opening the surface of the cornea. This means the procedure is minimal-invasive.

The study hypothesis is: Different types of ametropia can be corrected safely and on long-term by intrastromal cuts.

Condition or Disease Intervention/Treatment Phase
  • Device: Intrastromal Correction of Presbyopia
  • Device: Intrastromal correction of Myopia
  • Device: Intrastromal Correction of Hyperopia
  • Device: Intrastromal Correction of Myopia incl. Astigmatism
  • Device: Intrastromal Correction of Hyperopia incl. Astigmatism
Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Intrastromal Correction of Ametropia by a Femtosecond Laser
Study Start Date :
Jul 1, 2008
Actual Primary Completion Date :
Jan 1, 2009
Anticipated Study Completion Date :
Dec 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1 / Presbyopia

Presbyopic patients, slightly hyperopes

Device: Intrastromal Correction of Presbyopia
Applying defined, pre-programmed patterns (e.g. rings and/or radial cuts)into the human eye cornea. It is a minimal-invasive procedure which changes the topography of the cornea and by that the refraction ability.
Other Names:
  • - FEMTEC Laser System
  • - Patient Interface
  • Experimental: 2 / Myopia

    Myopic patients without Astigmatism

    Device: Intrastromal correction of Myopia
    Applying defined, pre-programmed patterns (e.g. rings and/or radial cuts)into the human eye cornea. It is a minimal-invasive procedure which changes the topography of the cornea and by that the refraction ability.
    Other Names:
  • FEMTEC Laser System
  • Experimental: 3 / Hyperopia

    Hyperope patients without Astigmatism

    Device: Intrastromal Correction of Hyperopia
    Applying defined, pre-programmed patterns (e.g. rings and/or radial cuts)into the human eye cornea. It is a minimal-invasive procedure which changes the topography of the cornea and by that the refraction ability.
    Other Names:
  • FEMTEC Laser System
  • Experimental: 4 / Myopia with Astigmatism

    Myopic patients incl. Astigmatism

    Device: Intrastromal Correction of Myopia incl. Astigmatism
    Applying defined, pre-programmed patterns (e.g. rings and/or radial cuts)into the human eye cornea. It is a minimal-invasive procedure which changes the topography of the cornea and by that the refraction ability.
    Other Names:
  • FEMTEC Laser System
  • Experimental: 5 / Hyperopia with Astigmatism

    Hyperope patients incl. Astigmatism

    Device: Intrastromal Correction of Hyperopia incl. Astigmatism
    Applying defined, pre-programmed patterns (e.g. rings and/or radial cuts)into the human eye cornea. It is a minimal-invasive procedure which changes the topography of the cornea and by that the refraction ability.
    Other Names:
  • FEMTEC Laser System
  • Outcome Measures

    Primary Outcome Measures

    1. Prove safety and effectiveness as well as improvement in near visual acuity performance and increase in near visual acuity. [3 months]

    Secondary Outcome Measures

    1. Validate the 3 months results [6 months]

    2. Prove stability of distance visual acuity and safety of the procedure regarding infections and inflammatory response as well as corneal endothelial cell counts. [6 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • age: > 18 years

    • stable distance refraction for at least one year (i.e. a maximum change of 0.5 D)

    • in the case of presbyopia: minimum near add +2D to + 4D

    • in the case of myopia or hyperopia (without astigmatism): minimal 1D and maximum 3D

    • in the case of myopia or hyperopia (with astigmatism): spherical equivalent of minimal 1D and maximum 3D

    • BSCVA of the eye to be treated >= 0.63

    • patients are willing and in such conditions to come to the follow-up exams

    • no further ocular pathologies

    Exclusion Criteria:
    • age: < 18 years

    • refraction less than +/- 1 D or higher than +/- 3 D (not valid for presbyopia patients)

    • minimal pachymetry of < 500µm

    • K-mean < 37 D or > 60 D

    • Difference (K-max minus K-min) > 5D

    • Difference cycloplegic refraction to subjective refraction more than 1 D (valid only for hyperopia correction)

    • patients with previous intraocular or corneal surgeries (e.g. post-LASIK or PRK patients). Exemption: standard cataract surgery.

    • patients with one or more of the following ocular pathologies:

    • keratokonus

    • corneal scars

    • transplanted cornea

    • disorders of wound healing

    • trauma

    • glaucoma

    • epilepsia

    • nystagmus

    • lack of concentration

    • other complicated illnesses

    • diabetes mellitus

    • instable K-readings as a sign of instable cornea

    • weakness of connective tissue

    • sensitivity against the drugs used in the study

    • continuous wearing of contact lenses before the pre-exam, and before the surgery. At least 14 days before these dates patients must abstain from wearing CL.

    • patients in pregnancy or during lactation

    • patients who take part in another clinical trial

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Klinik für Refraktive und Ophthalmo-Chirurgie des EJK Niederrhein Duisburg Germany 47169
    2 FreeVis LASIK Zentrum Mannheim GmbH Mannheim Germany 68167
    3 Augenklinik am Marienplatz AG & Co. KG Muenchen Germany 80331

    Sponsors and Collaborators

    • 20/10 Perfect Vision

    Investigators

    • Principal Investigator: Gerd U. Auffarth, Prof. Dr., Universitäts-Augenklinik Heidelberg

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00928122
    Other Study ID Numbers:
    • ISCAF
    First Posted:
    Jun 25, 2009
    Last Update Posted:
    Feb 9, 2010
    Last Verified:
    Feb 1, 2010
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 9, 2010